1
|
Lyakhovitsky A, Zilberminz T, Segal Z, Galili E, Shemer A, Jaworowsk B, Baum S, Hermush V, Kaplan B, Barzilai A. Exploring Remission Dynamics and Prognostic Factors in Lichen Planopilaris: a Retrospective Cohort Study. Dermatology 2024:000538355. [PMID: 38574470 DOI: 10.1159/000538355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2023] [Accepted: 03/10/2024] [Indexed: 04/06/2024] Open
Abstract
INTRODUCTION Lichen planopilaris (LPP) is a common type of primary cicatricial alopecia. Previous studies focused on the epidemiology, clinical characteristics, and treatment of LPP. A lack of knowledge regarding LPP outcomes and prognostic factors remained. METHODS To delineate the rate and timing of remission in LPP, as well as the prognostic factors for achieving remission, a retrospective cohort study was conducted. The study included 126 patients, from a single tertiary center, diagnosed with LPP between January 2010 and December 2022, who were followed up for a minimum of 6 months. RESULTS There were 89 (70.6%) women and 37 (29.4 %) men included in this study. The mean age of the patients was 47.92±14.2 years. The mean time from disease onset to diagnosis was 33.85 (±30) months, indicating significant diagnostic delays. The mean duration of follow-up was 34.13±22.7 months. Among the cohort, 43 patients achieved complete remission (CR) during the follow-up period, whereas 83 patients did not. Of the 83 patients who did not achieve CR, 35 partially improved and 48 did not improve or worsened. The median time for achieving CR was 46±18.8 months. Milder disease at presentation and comorbid lichen planus were associated with higher CR rates. CONCLUSION This study demonstrates significant diagnostic delays that should be addressed as LPP causes irreversible alopecia, suggests disease severity and comorbid lichen planus as potential prognostic factors. Further, it emphasizes the limited efficacy of current treatments and the need for prolonged treatment in patients with LPP to achieve remission.
Collapse
|
2
|
Vijayaraghavan K, Baum S, Desai NR, Voyce SJ. Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins. Front Cardiovasc Med 2024; 10:1308173. [PMID: 38288054 PMCID: PMC10822878 DOI: 10.3389/fcvm.2023.1308173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Accepted: 12/28/2023] [Indexed: 01/31/2024] Open
Abstract
Introduction Statins remain the first-line treatment for secondary prevention of cardiovascular (CV) events, with lowering of low-density lipoprotein cholesterol (LDL-C) being their therapeutic target. Although LDL-C reduction significantly lowers CV risk, residual risk persists, even in patients with well-controlled LDL-C; thus, statin add-on agents that target pathways other than LDL-C, such as the omega-3 fatty acid eicosapentaenoic acid, may help to further reduce persistent CV risk in patients with established CV disease. Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins. Results CV event rates among patients treated with statins who have established CV disease, including coronary artery disease, cerebrovascular disease, or peripheral arterial disease, accumulate over time, with a cumulative incidence of CV events reaching up to approximately 40% over 10 years. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event. Repeat revascularization and CV-related death occurs in up to 38% and 33% of patients with peripheral artery disease after three years, respectively. Discussion Additional treatment strategies, such as eicosapentaenoic acid, are needed to reduce persistent CV risk in patients with established CV disease treated with statins.
Collapse
Affiliation(s)
- K. Vijayaraghavan
- Division of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, United States
| | - S. Baum
- Flourish Research, Boca Raton, FL, United States
- Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, United States
| | - N. R. Desai
- Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States
| | - S. J. Voyce
- Clinical Cardiology Research, Geisinger Heart Institute, Scranton, PA, United States
| |
Collapse
|
3
|
Kassem R, Barzilai A, Baum S, Kempfner A, Pavlotsky F. Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study. Mycoses 2023; 66:1064-1070. [PMID: 37620517 DOI: 10.1111/myc.13651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Revised: 08/01/2023] [Accepted: 08/04/2023] [Indexed: 08/26/2023]
Abstract
BACKGROUND Tinea capitis (TC), a fungal infection that occurs in children, is primarily caused by dermatophytes such as Trichophyton and Microsporum species. For Trichophyton species, treatment with terbinafine is considered more effective than griseofulvin treatment. Specific populations, such as refugee children, are more susceptible to TC. OBJECTIVE This study aimed to describe and compare the response to treatment among Israeli and refugee children with TC. PATIENTS/METHODS We retrospectively reviewed data collected on refugee and Israeli children with TC between January 2004 and January 2020. RESULTS Overall, 3358 children with TC (refugees: 1497; Israelis: 1861) were identified. Among these, 86% of the refugee children had TC caused by Trichophyton violaceum, 65% of the Israeli children had TC caused by Microsporum canis and 83% of all children were treated with griseofulvin. Overall, 14% of the refugees showed a partial response to a griseofulvin dose of ≤25 mg/kg/day; however, they showed a complete response upon increasing the dose to ≥30 mg/kg/day. No significant adverse effects were observed. CONCLUSION The over-crowded day care centres and dense living make refugee children more susceptible to TC than the general population, and griseofulvin dosage adjustment is necessary. TC, due to Trichophyton species, could benefit from receiving an increased dose of griseofulvin in a suspension form, which is cheaper than terbinafine.
Collapse
Affiliation(s)
- R Kassem
- Dermatology Department, Sheba Medical Center, Ramat Gan, Israel
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - A Barzilai
- Dermatology Department, Sheba Medical Center, Ramat Gan, Israel
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - S Baum
- Dermatology Department, Sheba Medical Center, Ramat Gan, Israel
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - A Kempfner
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - F Pavlotsky
- Dermatology Department, Sheba Medical Center, Ramat Gan, Israel
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|
4
|
ZHURAVLEVA N, Vorobiova O, Mineeva N, Horoshev S, Telina A, Baum S, Averyanov O, Makarovskaya M. WCN23-1009 MORPHOLOGICAL AND MOLECULAR GENETIC VERIFICATION OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CHILDREN. Kidney Int Rep 2023. [DOI: 10.1016/j.ekir.2023.02.959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2023] Open
|
5
|
Barzilai A, Segal O, Goldzweig G, Bratt IS, Baum S, Lyakhovitsky A. Illness perception of early-stage mycosis fungoides among dermatologists: a multi-center cross-sectional study. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00619-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
6
|
Murrell DF, Patsatsi A, Stavropoulos P, Baum S, Zeeli T, Kern JS, Sinclair R, Neale A, Arora P, Sugerman PB, Shi G, Werth VP, Caux F, Joly P. Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol 2022; 36. [PMID: 35686647 DOI: 10.1111/jdv.18318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 05/30/2022] [Indexed: 11/30/2022]
Affiliation(s)
- D F Murrell
- Department of Dermatology, St George Hospital, University of New South Wales Faculty of Medicine, Sydney, Australia
| | - A Patsatsi
- 2nd Dermatology Department, Aristotle University Faculty of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| | - P Stavropoulos
- 1st Department of Dermatology, National and Kapodistrian University, School of Medicine, Athens, Greece
| | - S Baum
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - T Zeeli
- Department of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - J S Kern
- Dermatology Department, The Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia
| | - R Sinclair
- University of Melbourne and Sinclair Dermatology, Victoria, Australia
| | - A Neale
- Principia Biopharma Inc, a Sanofi Company, South San Francisco, California, United States
| | - P Arora
- Principia Biopharma Inc, a Sanofi Company, South San Francisco, California, United States
| | - P B Sugerman
- Global Medical Affairs, Sanofi Genzyme, Cambridge, Massachusetts, United States
| | - G Shi
- Biostatistics, Sanofi US Services Inc., Bridgewater, New Jersey, United States
| | - V P Werth
- University of Pennsylvania Perelman School of Medicine and Corporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania, United States
| | - F Caux
- Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, AP-, HP, Bobigny, France
| | - P Joly
- Department of Dermatology, Rouen University Hospital, Centre de Référence des Maladies Bulleuses Autoimmunes, and INSERM U1234, Normandie University, Rouen, France
| |
Collapse
|
7
|
Gitas G, Alkatout I, Proppe L, Hanker L, Allahqoli L, Grimbizis G, Rody A, Werner N, Sommer S, Baum S. Long-term satisfaction of patients after laparoscopic and robotic-assisted hysterectomy. Arch Gynecol Obstet 2021; 305:1481-1490. [PMID: 34954814 PMCID: PMC9166875 DOI: 10.1007/s00404-021-06360-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Accepted: 12/06/2021] [Indexed: 11/26/2022]
Abstract
Introduction Da-Vinci-Xi is the most recent device used in gynecologic robotic surgery. The aim of the present study was to compare the long-term satisfaction of patients who had undergone conventional laparoscopic hysterectomy or robotic assisted laparoscopic hysterectomy using the Da-Vinci-Xi surgical system. Methods All hysterectomies performed at the University Hospital of Luebeck from 2018 to 2019 were reviewed. Postoperative outcomes were compared between women who had undergone total hysterectomy with da Vinci Xi (n = 42) or conventional laparoscopy (n = 97). Postoperative outcomes included pain, elimination of complaints after surgery, bladder function, sexual function, satisfaction with the cosmetic outcome, positive experiences after robotic surgery, and satisfaction with the surgeon’s preoperative explanation. Obese patients were evaluated separately in a subgroup analysis. Results Both groups had similar baseline characteristics and complication rates. Preoperative complaints subsided after surgery in a little more than 90% of patients. No significant differences were noted between groups in this regard (p = 0.262), or with reference to postoperative pain after one week (p = 0.866) and one month (p = 0.580), stress incontinence (p = 0.343), sexual function (p = 0.766) and the cosmetic outcome of the abdominal incisions (p = 0.273). The majority of patients who had undergone robotic surgery (96.8%) would be willing to undergo the procedure again if necessary. The subgroup analysis of obese patients revealed no significant differences. Conclusion The Da-Vinci-Xi device did not improve the long-term surgical satisfaction of normal-weight or obese patients who underwent hysterectomy compared with patients who underwent conventional laparoscopy performed by experienced laparoscopic surgeons.
Collapse
Affiliation(s)
- Georgios Gitas
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany.
| | - I Alkatout
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Kiel, Kiel, Germany
| | - L Proppe
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - L Hanker
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - L Allahqoli
- School of Public Health, Iran University of Medical Sciences (IUMS), Tehran, Iran
| | - G Grimbizis
- First Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - A Rody
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - N Werner
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - S Sommer
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - S Baum
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| |
Collapse
|
8
|
Baniel A, Oestreicher-Kedem Y, Peled A, Bar-Ilan E, Geller S, Sprecher E, Baum S. Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab. Clin Exp Dermatol 2021; 46:915-919. [PMID: 33811681 DOI: 10.1111/ced.14662] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Revised: 03/21/2021] [Accepted: 03/30/2021] [Indexed: 11/29/2022]
Abstract
Mucous membrane pemphigoid (MMP) is an autoimmune blistering, scarring and occasionally mutilating disease that may progress to blindness or airway obstruction. Over the past few years, rituximab (RTX) has emerged as a potential therapeutic solution for MMP; however, the literature regarding its efficacy in the treatment of severe MMP is sparse. We studied four patients with recalcitrant MMP who were treated with RTX. Three of these had recalcitrant laryngeal disease; two were unresponsive to RTX, while the third patient achieved complete remission (CR) but relapsed twice. The fourth patient, who had oral and ocular disease, also achieved CR. In addition, we reviewed 143 cases of MMP treated with RTX reported in the literature to date. Of these, 120 had late observation endpoints, of whom 81 (67.5%) achieved CR, 24 (20%) received partial remission and 15 (12.5%) had no remission. Based on this study, the presence of laryngeal MMP seems to predict refractoriness to RTX treatment. In conclusion, we found that RTX can ameliorate the MMP course and that laryngeal involvement, which is known to be a prognostic factor for severe MMP, may also predict poor response to RTX.
Collapse
Affiliation(s)
- A Baniel
- Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Y Oestreicher-Kedem
- Department of Ear, Nose, Throat, Head and Neck Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - A Peled
- Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
| | - E Bar-Ilan
- Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
| | - S Geller
- Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - E Sprecher
- Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - S Baum
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Dermatology, Sheba Medical Centre, Ramat-Gan, Israel
| |
Collapse
|
9
|
Gitas G, Proppe L, Ertan AK, Baum S, Rody A, Kocaer M, Dinas K, Allahqoli L, Laganà AS, Sotiriadis A, Sommer S, Alkatout I. Influence of the second stage of labor on maternal and neonatal outcomes in vaginal births after caesarean section: a multicenter study in Germany. BMC Pregnancy Childbirth 2021; 21:356. [PMID: 33947354 PMCID: PMC8097953 DOI: 10.1186/s12884-021-03817-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2020] [Accepted: 04/20/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The American College of Obstetricians and Gynecologists (ACOG) introduced a new standard of care in 2014, extending the duration of the second stage of labor in order to reduce caesarean delivery (CD) rates and its severe complications. The aim of the present study is to evaluate success rates of trial of labor after caesarean section (TOLAC), as well as maternal and neonatal outcomes after the establishment of the recent guidelines. METHODS A retrospective study was performed at two large departments in Germany from January 2008 to January 2018. Patients undergoing TOLAC were divided into two groups. Group I (958 patients) was constituted before the establishment of the current guidelines, and Group II (588 patients) after the establishment of the guidelines. A subgroup analysis was performed to compare neonatal outcomes after successful TOLAC and operative vaginal delivery with those after failed TOLAC and secondary CD. RESULTS The success rate of vaginal births after cesarean section (VBAC) fell from 66.4% in Group I to 55.8% in Group II (p < 0.001). The median duration of the second stage of labor was statistically significantly longer in Group II than in Group I (79.3 ± 61.9 vs. 69.3 ± 58.2 min) for patients without previous vaginal birth. The incidence of operative vaginal delivery decreased from Group I to Group II (9.6% vs. 6.8%). The incidence of third- and fourth-degree perineal lacerations, blood loss and emergency CD were similar in the two groups. Concerning the neonatal outcome, our groups did not differ significantly in regard of rates of umbilical artery cord pH < 7.1 (p = 0.108), the 5-min Apgar scores below 7 (p = 0.224) and intubation (p = 0.547). However, the transfer rates to the neonatal care unit were significantly higher in Group II than in Group I (p < 0.001). Neonatal outcomes did not differ significantly in the subgroup analysis. CONCLUSION Extending the second stage of labor does not necessarily result in more vaginal births after TOLAC. Maternal and neonatal outcomes were similar in both groups. Further studies will be needed to evaluate the role of operative vaginal delivery and the duration of the second stage of labor in TOLAC.
Collapse
Affiliation(s)
- G Gitas
- Department of Obstetrics and Gynecology, University Hospital Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany.
| | - L Proppe
- Department of Obstetrics and Gynecology, University Hospital Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - A K Ertan
- Department of Obstetrics and Gynecology, Leverkusen Municipal Hospital, Leverkusen, 51375, Germany
| | - S Baum
- Department of Obstetrics and Gynecology, University Hospital Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - A Rody
- Department of Obstetrics and Gynecology, University Hospital Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - M Kocaer
- Department of Obstetrics and Gynecology, Leverkusen Municipal Hospital, Leverkusen, 51375, Germany
| | - K Dinas
- Second Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Konstaninoupoleos 49, Thessaloniki, 546 42, Greece
| | - L Allahqoli
- School of Public Health, Iran University of Medical Sciences (IUMS), Tehran, 14535, Iran
| | - A S Laganà
- Department of Obstetrics and Gynecology, Filippo Del Ponte Hospital, University of Insubria, Varese, Italy
| | - A Sotiriadis
- Second Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Konstaninoupoleos 49, Thessaloniki, 546 42, Greece
| | - S Sommer
- Department of Obstetrics and Gynecology, University Hospital Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - I Alkatout
- Department of Obstetrics and Gynecology, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany
| |
Collapse
|
10
|
Murrell DF, Patsatsi A, Stavropoulos P, Baum S, Zeeli T, Kern JS, Roussaki-Schulze AV, Sinclair R, Bassukas ID, Thomas D, Neale A, Arora P, Caux F, Werth VP, Gourlay SG, Joly P. Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study. Br J Dermatol 2021; 185:745-755. [PMID: 33942286 PMCID: PMC8518737 DOI: 10.1111/bjd.20431] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/30/2021] [Indexed: 01/01/2023]
Abstract
Background Bruton tyrosine kinase (BTK) inhibition targets B‐cell and other non‐T‐cell immune cells implicated in the pathophysiology of pemphigus, an autoimmune disease driven by anti‐desmoglein autoantibodies. Rilzabrutinib is a new reversible, covalent BTK inhibitor demonstrating preclinical efficacy as monotherapy in canine pemphigus foliaceus. Objectives To evaluate the efficacy and safety of oral rilzabrutinib in patients with pemphigus vulgaris in a multicentre, proof‐of‐concept, phase II trial. Methods Patients with Pemphigus Disease Area Index severity scores 8–45 received 12 weeks of oral rilzabrutinib 400–600 mg twice daily and 12 weeks of follow‐up. Patients initially received between 0 and ≤ 0·5 mg kg−1 prednisone‐equivalent corticosteroid (CS; i.e. ‘low dose’), tapered after control of disease activity (CDA; no new lesions, existing lesions healing). The primary endpoints were CDA within 4 weeks on zero‐to‐low‐dose CS and safety. Results In total, 27 patients with pemphigus vulgaris were included: nine newly diagnosed (33%) and 18 relapsing (67%); 11 had moderate disease (41%) and 16 moderate to severe (59%). The primary endpoint, CDA, was achieved in 14 patients (52%, 95% confidence interval 32–71): 11 using low‐dose CS and three using no CS. Over 12 weeks of treatment, mean CS doses reduced from 20·0 to 11·8 mg per day for newly diagnosed patients and from 10·3 to 7·8 mg per day for relapsing patients. Six patients (22%) achieved complete response by week 24, including four (15%) by week 12. Treatment‐related adverse events were mostly mild (grade 1 or 2); one patient experienced grade 3 cellulitis. Conclusions Rilzabrutinib alone, or with much lower CS doses than usual, was safe, with rapid clinical activity in pemphigus vulgaris. These data suggest that BTK inhibition may be a promising treatment strategy and support further investigation of rilzabrutinib for the treatment of pemphigus. What is already known about this topic?Standard pemphigus treatment relies on systemic high‐dose corticosteroids (CS), rituximab and/or immunosuppressives, which are limited by delayed onset of action and potential toxicities. Immune‐mediated mechanisms that are fast acting on both the innate and adaptive immune systems, are steroid sparing, and have safety profiles well suited for chronic administration are greatly needed for patients with pemphigus.
What does this study add?Rilzabrutinib is an oral Bruton tyrosine kinase (BTK) inhibitor targeting B‐cell and other non‐T‐cell immune cells implicated in pemphigus pathophysiology. Treatment with rilzabrutinib (with or without low‐dose CS) demonstrated rapid disease control and a well‐tolerated safety profile in patients with newly diagnosed and relapsing pemphigus vulgaris. BELIEVE provides evidence for a promising treatment strategy via BTK inhibition, supporting further investigation of rilzabrutinib in other immune‐mediated diseases.
Linked Comment: A.M. Drucker and N.H. Shear. Br J Dermatol 2021; 185:691–692. Plain language summary available online
Collapse
Affiliation(s)
- D F Murrell
- Department of Dermatology, St George Hospital, University of New South Wales Faculty of Medicine, Sydney, NSW, Australia
| | - A Patsatsi
- 2nd Dermatology Department, Aristotle University Faculty of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| | - P Stavropoulos
- 1st Department of Dermatology, National and Kapodistrian University, School of Medicine, Athens, Greece
| | - S Baum
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - T Zeeli
- Department of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - J S Kern
- Dermatology Department, The Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Melbourne, VIC, Australia
| | - A-V Roussaki-Schulze
- Department of Dermatology, University General Hospital of Larissa, Larissa, Greece
| | - R Sinclair
- University of Melbourne and Sinclair Dermatology, Melbourne, VIC, Australia
| | - I D Bassukas
- Department of Skin and Venereal Diseases, School of Health Sciences, University of Ioannina, Ioannina, Greece
| | - D Thomas
- Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA, USA
| | - A Neale
- Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA, USA
| | - P Arora
- Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA, USA
| | - F Caux
- Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, AP-HP, Bobigny, France
| | - V P Werth
- University of Pennsylvania and Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA
| | - S G Gourlay
- Principia Biopharma Inc., a Sanofi Company, South San Francisco, CA, USA
| | - P Joly
- Department of Dermatology, Rouen University Hospital, Centre de Référence des Maladies Bulleuses Autoimmunes, and INSERM U1234, Normandie University, Rouen, France
| | | |
Collapse
|
11
|
Gitas G, Eckhoff K, Rody A, Ertan AK, Baum S, Hoffmans E, Alkatout I. An unprecedented occult non-communicating rudimentary uterine horn treated with laparoscopic excision and preservation of both fallopian tubes: a case report and review of the literature. J Med Case Rep 2021; 15:51. [PMID: 33536066 PMCID: PMC7860579 DOI: 10.1186/s13256-020-02636-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2019] [Accepted: 12/15/2020] [Indexed: 11/10/2022] Open
Abstract
Background Müllerian duct anomalies are congenital malformations of the female genital tract and may be of various types. For decades they have been classified according to the American Society of Reproductive Medicine, which mentions unicornuate uterine malformations as the second subgroup. They result from the arrested development of one of the Müllerian ducts and appear in approximately 1/1000 women. These anomalies are usually diagnosed in the second decade of life, because they tend to remain asymptomatic until adolescence and their initial symptoms may vary. Patients present with symptoms such as dysmenorrhea, infertility, and chronic or acute abdominal pain. Case presentation We report on a 21-year-old Caucasian German patient who suffered from dysmenorrhea for 7 years. After a transvaginal ultrasound and magnetic resonance tomography of the pelvis was performed, the patient underwent a diagnostic hysteroscopy and operative laparoscopy, and was finally diagnosed with a Müllerian duct anomaly presenting with a non-communicating rudimentary uterine horn. The left tube arose directly in orthotopic location from the cornua of uterus, with no connection to the rudimentary uterine horn or structure. Conclusion The anatomic features of this case have not been reported previously and were not consistent with any existing classification. More cases are needed in order to confirm our hypothesis. Gynecologists should always consider Müllerian anomalies as an important differential diagnosis in young patients with abdominal pain.
Collapse
Affiliation(s)
- G Gitas
- Department of Obstetrics and Gynecology, University Hospitals Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany.
| | - K Eckhoff
- Department of Obstetrics and Gynecology, University Hospitals Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - A Rody
- Department of Obstetrics and Gynecology, University Hospitals Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - A K Ertan
- Department of Obstetrics and Gynecology, Leverkusen Municipality Hospital, Leverkusen, Germany
| | - S Baum
- Department of Obstetrics and Gynecology, University Hospitals Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - E Hoffmans
- Department of Obstetrics and Gynecology, Leverkusen Municipality Hospital, Leverkusen, Germany
| | - I Alkatout
- Department of Obstetrics and Gynecology, University Hospitals Schleswig Holstein, Campus Kiel, Kiel, Germany
| |
Collapse
|
12
|
Gitas G, Proppe L, Baum S, Kruggel M, Rody A, Tsolakidis D, Zouzoulas D, Laganà AS, Guenther V, Freytag D, Alkatout I. A risk factor analysis of complications after surgery for vulvar cancer. Arch Gynecol Obstet 2021; 304:511-519. [PMID: 33420814 PMCID: PMC8277626 DOI: 10.1007/s00404-020-05949-w] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2020] [Accepted: 12/23/2020] [Indexed: 12/14/2022]
Abstract
Introduction Despite the less frequent use of surgery in patients with vulvar cancer, the high rates of postoperative complications are still a matter of concern. The aim of the present study was to identify risk factors that influence postoperative complications rates in vulvar cancer and identify specific clinical parameters that may influence their incidence.
Materials Patients who underwent curative-intent surgery for squamous cell carcinoma of the vulva from 2003 to 2018 were selected. All patient characteristics were analyzed as risk factors for the development of postoperative lymphocele, lymphedema, and wound dehiscence. The patients were followed up for 2 years postoperatively.
Results The investigation comprised 121 patients, of whom 18.1% developed wound dehiscence, 17.7% a lymphocele, and 20.4% lymphedema. We found no significant evidence of an association between patient’s characteristics and postoperative complications. The depth of tumor invasion and the appearance of lymph-node metastasis were significantly associated with postoperative complications. Free resection margins of 5 mm or more were associated with a reduced risk of postoperative complications compared to resection margins less than 5 mm. No complications were encountered after sentinel node biopsy (SNB). Complication rates were associated with inguinofemoral lymphadenectomy, but not with the extent of lymphadenectomy. The development of a lymphocele or wound dehiscence may be correlated with the development of long-term lymphedema. Conclusion FIGO stage at diagnosis influences the risk of postoperative complications. The use of SNB minimized postoperative complications. Correlations between the free microscopic resection margin distance and the risk of postoperative wound dehiscence must be investigated further.
Collapse
Affiliation(s)
- Georgios Gitas
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany.
| | - L Proppe
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - S Baum
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - M Kruggel
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - A Rody
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, Haus A, 23538, Luebeck, Germany
| | - D Tsolakidis
- First Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - D Zouzoulas
- First Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - A S Laganà
- Department of Obstetrics and Gynecology, Filippo Del Ponte Hospital, University of Insubria, Varese, Italy
| | - V Guenther
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Kiel, Kiel, Germany
| | - D Freytag
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Kiel, Kiel, Germany
| | - I Alkatout
- Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Kiel, Kiel, Germany
| |
Collapse
|
13
|
Raal F, Rosenson R, Reeskamp L, Kastelein J, Baum S, Ali S, Banerjee P, Chan KC, Gipe D, Pordy R, Gaudet D. The efficacy and safety of evinacumab in homozygous familial hypercholesterolaemia (HoFH) patients with little to no low-density lipoprotein receptor (LDLR) activity. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
14
|
White K, Sierra G, Baum S, Hopkins K, Potter J, Grossman D. P19 Attitudes about second-trimester abortion and the impact of restrictive laws among reproductive-aged Texas women. Contraception 2020. [DOI: 10.1016/j.contraception.2020.07.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Raifman S, Sierra G, Grossman D, Baum S, Hopkins K, Potter J, White K. O1 Out-of-state abortions increased for Texas residents after House Bill 2. Contraception 2020. [DOI: 10.1016/j.contraception.2020.07.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
16
|
Affiliation(s)
- A Lyakhovitsky
- Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
| | - T Drousiotis
- Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
| | - H Landov
- Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
| | - S Baum
- Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
| | - A Barzilai
- Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.,Institute of Pathology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
| |
Collapse
|
17
|
Ben Mordehai Y, Faibish H, Astman N, Greenberger S, Barzilai A, Baum S. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid. J Eur Acad Dermatol Venereol 2019; 34:161-165. [PMID: 31423677 DOI: 10.1111/jdv.15883] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2019] [Accepted: 07/17/2019] [Indexed: 12/20/2022]
Abstract
BACKGROUND Bullous pemphigoid (BP) is the most common subepidermal autoimmune blistering disease. Patients occasionally present with a clinical picture of pruritus/urticaria alone for months and do not even develop blisters over time. Only few studies have investigated this subgroup of non-bullous pemphigoid (NBP). OBJECTIVE To evaluate the demographic and clinical characteristics of BP patients with or without blisters at the time of diagnosis. METHODS A retrospective study based on the medical records of 115 BP patients. Collected data included demographic characteristics, clinical presentation, treatment and response to treatment. RESULTS Thirty-six patients presented with pruritus/urticaria (31.3%), and 79 presented with blisters (68.7%), with mean ages of 77.5 and 76.0, respectively, at diagnosis and an equal female:male ratio. The level of immunoglobulin E (IgE) was 4.1 times higher, and the mean blood eosinophil count was significantly increased in the pruritus/urticaria group. Remission rate at 3 months and relapse rate were similar between the groups. Median follow-up period was 9 months (range 3-18). Only 23% of the patients with pruritus/urticaria developed blisters. CONCLUSIONS A significant number of BP patients present without blisters. We found no significant epidemiological or clinical differences from the classic BP patients aside from significantly elevated IgE and blood eosinophil levels. Similar results in larger cohort studies might be the foundation for a change in clinical protocols regarding the diagnosis and recommended treatment for the elderly presenting with pruritus/urticaria only.
Collapse
Affiliation(s)
- Y Ben Mordehai
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - H Faibish
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - N Astman
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.,Israel Defense Forces Medical Corps, Ramat Gan, Israel
| | - S Greenberger
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - A Barzilai
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - S Baum
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|
18
|
Gitas G, Proppe L, Alkatout I, Rody A, Kotanidis C, Tsolakidis D, Baum S. Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany. Arch Gynecol Obstet 2019; 300:169-174. [DOI: 10.1007/s00404-019-05158-0] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Accepted: 04/06/2019] [Indexed: 11/24/2022]
|
19
|
Lyakhovitsky A, Aronovich A, Gilboa S, Baum S, Barzilai A. Alopecia areata: a long-term follow-up study of 104 patients. J Eur Acad Dermatol Venereol 2019; 33:1602-1609. [PMID: 30887594 DOI: 10.1111/jdv.15582] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Accepted: 02/27/2019] [Indexed: 12/01/2022]
Abstract
BACKGROUND Alopecia areata (AA) is a common autoimmune disease that considerably affects the quality of life. Although several studies have investigated the epidemiology, clinical characteristics and treatment of AA, limited recent data are available regarding its long-term course. OBJECTIVES To evaluate the long-term course of AA in different age groups. METHODS A retrospective evaluation of patients who were newly diagnosed with AA from 2008 to 2011 and had at least 7 years of follow-up. Data regarding the initial episode, treatment given, disease-free interval and relapses were analysed. RESULTS A total of 104 cases were analysed: 31 childhood-onset, 63 adult-onset and 10 late-onset. At first episode, 88.5% of patients had mild, 3.8% moderate and 7.7% severe AA. Full or significant re-growth was observed in 74%, 94% and 100% of childhood-onset, adult-onset and late-onset AA patients, respectively. There was no re-growth in 13%, 3% and 0% of childhood-onset, adult-onset and late-onset patients, respectively. The duration of the initial episode and the disease-free interval negatively correlated with age. Systemic steroids were the most effective treatment for the primary episode. The frequency of relapses was high overall (52%, 44% and 30% in childhood-onset, adult-onset and late-onset, respectively), but significantly declined over time with a majority (79%) occurring within the first 4 years. The disease-free interval and relapse rate were not correlated with gender, disease severity at onset or treatment given. CONCLUSIONS The prevalence of severe disease, duration of an initial episode and the rate of relapses decreased with an older age at onset. In addition, the outcome and the disease-free interval improved with age at onset. The frequency of relapses declined over time and most appear early on. The current treatment modalities do not seem to influence the long-term outcome.
Collapse
Affiliation(s)
- A Lyakhovitsky
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - A Aronovich
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - S Gilboa
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - S Baum
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel.,Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - A Barzilai
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel.,Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| |
Collapse
|
20
|
Meier S, Köster F, Baum S, Rody A, Bräutigam K. Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1675452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- S Meier
- Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - F Köster
- Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - S Baum
- Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - A Rody
- Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - K Bräutigam
- Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| |
Collapse
|
21
|
Baum S, Fix L, Durden M, Stoeffler C, Hastings J, Moseson H, Obedin-Maliver J. Family planning needs and experiences of transgender and gender-expansive individuals in the United States: a qualitative study. Contraception 2018. [DOI: 10.1016/j.contraception.2018.07.112] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
22
|
Meier S, Köster F, Baum S, Rody A, Bräutigam K. Analysis and comparison of HPV genotypes between different sites of the female anogenital tract and the oropharynx. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- S Meier
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - F Köster
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - S Baum
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - A Rody
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - K Bräutigam
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| |
Collapse
|
23
|
Bräutigam K, Ehret C, Köster F, Rody A, Baum S, Panning M. Analytical performance evaluation and HPV genotype-specific concordance between EUROarray HPV and HPV 3.5 LCD-Array Kit in 163 German cervical samples. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- K Bräutigam
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - C Ehret
- Institut für Virologie, Universitätsklinikum Freiburg, Department für Medizinische Mikrobiologie & Hygiene, Freiburg, Deutschland
| | - F Köster
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - A Rody
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - S Baum
- Klinik für Frauenheilkunde und Geburtshilfe, UK-SH, Campus Lübeck, Experimentelle gynäkologische Onkologie, Lübeck, Deutschland
| | - M Panning
- Institut für Virologie, Universitätsklinikum Freiburg, Department für Medizinische Mikrobiologie & Hygiene, Freiburg, Deutschland
| |
Collapse
|
24
|
Gitas G, Ertan KA, Rody A, Baum S, Hanker L, Kotanidis C. Incidence of unexpected uterus malignomas after power morcellation and survival outcome's analysis. A retrospective multicenter study in Germany. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- G Gitas
- University Hospital Schleswig Holstein, Campus Luebeck, Department of Gynaecology and Obstetrics, Lübeck, Deutschland
| | - KA Ertan
- Leverkusen Municipal Hospital, Leverkusen, Deutschland
| | - A Rody
- University Hospital Schleswig Holstein, Campus Luebeck, Department of Gynaecology and Obstetrics, Lübeck, Deutschland
| | - S Baum
- University Hospital Schleswig Holstein, Campus Luebeck, Department of Gynaecology and Obstetrics, Lübeck, Deutschland
| | - L Hanker
- University Hospital Schleswig Holstein, Campus Luebeck, Department of Gynaecology and Obstetrics, Lübeck, Deutschland
| | - C Kotanidis
- University Hospital Schleswig Holstein, Campus Luebeck, Department of Gynaecology and Obstetrics, Lübeck, Deutschland
| |
Collapse
|
25
|
Murrell D, Stavropoulos P, Patsatsi A, Zeeli T, Baum S, Bassukas I, Caux F, Roussaki A, Sinclair R, Kern J, Gourlay S, Joly P. LB1509 Anti-desmoglein levels & response to the BTK inhibitor PRN1008 in pemphigus. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.06.040] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Chu A, Baum S, Seckin T. Recurrent Catamenial Pneumothorax in the Endometriosis Patient. J Minim Invasive Gynecol 2017. [DOI: 10.1016/j.jmig.2017.08.371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
27
|
Baum S, Gulersen M, Hershlag A, Mullin C, Chu A, Shay A, Singer T. An Unconventional Choice of Embryo Transfer Day of a Frozen Embryo Transfer on a Fresh Endometrium Following Retrieval. J Minim Invasive Gynecol 2017. [DOI: 10.1016/j.jmig.2017.08.562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
28
|
Baum S, Chu A, Seckin T. Transcervical Specimen Removal: An Opportunity for Natural Orifice Surgery. J Minim Invasive Gynecol 2017. [DOI: 10.1016/j.jmig.2017.08.508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
29
|
White K, Baum S, Hopkins K, Potter JE, Grossman D. Change in distance to nearest facility and increase in second-trimester abortion after the implementation of House Bill 2 in Texas. Contraception 2017. [DOI: 10.1016/j.contraception.2017.07.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
30
|
Moseson HS, Gerdts C, Fuentes L, Baum S, White K, Hopkins K, Potter JE, Grossman D. Measuring Texas women’s experiences with abortion self-induction using a list experiment. Contraception 2017. [DOI: 10.1016/j.contraception.2017.07.042] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Miron G, Gurevich M, Baum S, Achiron A, Barzilai A. Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case - control analysis. J Eur Acad Dermatol Venereol 2017; 31:2055-2061. [DOI: 10.1111/jdv.14403] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2017] [Accepted: 06/02/2017] [Indexed: 12/17/2022]
Affiliation(s)
- G. Miron
- Multiple Sclerosis Center; Sheba Medical Center; Ramat Gan Israel
- Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel
| | - M. Gurevich
- Multiple Sclerosis Center; Sheba Medical Center; Ramat Gan Israel
| | - S. Baum
- Department of Dermatology; Sheba Medical Center; Ramat Gan Israel
| | - A. Achiron
- Multiple Sclerosis Center; Sheba Medical Center; Ramat Gan Israel
- Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel
| | - A. Barzilai
- Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel
- Department of Dermatology; Sheba Medical Center; Ramat Gan Israel
| |
Collapse
|
32
|
ElNaggar A, Coffman C, Talbot A, Baum S, Tillmanns T. Radiofrequency ablation for the treatment of recurrent gynecological malignancies: A case series. Gynecol Oncol 2017. [DOI: 10.1016/j.ygyno.2017.03.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Baum S, Sillem M, Ney JT, Baum A, Friedrich M, Radosa J, Kramer KM, Gronwald B, Gottschling S, Solomayer EF, Rody A, Joukhadar R. What Are the Advantages of 3D Cameras in Gynaecological Laparoscopy? Geburtshilfe Frauenheilkd 2017; 77:45-51. [PMID: 28190888 DOI: 10.1055/s-0042-120845] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Introduction Minimally invasive operative techniques are being used increasingly in gynaecological surgery. The expansion of the laparoscopic operation spectrum is in part the result of improved imaging. This study investigates the practical advantages of using 3D cameras in routine surgical practice. Materials and Methods Two different 3-dimensional camera systems were compared with a 2-dimensional HD system; the operating surgeon's experiences were documented immediately postoperatively using a questionnaire. Results Significant advantages were reported for suturing and cutting of anatomical structures when using the 3D compared to 2D camera systems. There was only a slight advantage for coagulating. The use of 3D cameras significantly improved the general operative visibility and in particular the representation of spacial depth compared to 2-dimensional images. There was not a significant advantage for image width. Depiction of adhesions and retroperitoneal neural structures was significantly improved by the stereoscopic cameras, though this did not apply to blood vessels, ureter, uterus or ovaries. Conclusion 3-dimensional cameras were particularly advantageous for the depiction of fine anatomical structures due to improved spacial depth representation compared to 2D systems. 3D cameras provide the operating surgeon with a monitor image that more closely resembles actual anatomy, thus simplifying laparoscopic procedures.
Collapse
Affiliation(s)
- S Baum
- Klinik für Frauenheilkunde und Geburtshilfe, UKSH Klinik für Frauenheilkunde und Geburtshilfe Campus Lübeck, Lübeck, Germany; Universitätsklinikum des Saarlandes, Klinik für Frauenheilkunde und Geburtshilfe, Homburg/Saar, Germany
| | - M Sillem
- Praxisklinik am Rosengarten, Mannheim, Germany
| | - J T Ney
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
| | - A Baum
- Praxis Prof. Dr. Dhom & Partner, Ludwigshafen, Germany
| | - M Friedrich
- Frauenklinik, HELIOS-Klinikum Krefeld, Krefeld, Germany
| | - J Radosa
- Universitätsklinikum des Saarlandes, Klinik für Frauenheilkunde und Geburtshilfe, Homburg/Saar, Germany
| | - K M Kramer
- Viszera Chirurgie-Zentrum, Munich, Germany
| | - B Gronwald
- Zentrum für Palliativmedizin und Kinderschmerztherapie, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - S Gottschling
- Universitätsklinikum des Saarlandes, Zentrum für Palliativmedizin und Kinderschmerztherapie, Homburg/Saar
| | - E F Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
| | - A Rody
- Klinik für Frauenheilkunde und Geburtshilfe, UKSH Klinik für Frauenheilkunde und Geburtshilfe Campus Lübeck, Lübeck, Germany
| | - R Joukhadar
- Universitätsfrauenklinik Würzburg, Würzburg, Germany
| |
Collapse
|
34
|
Joukhadar R, Baum S, Radosa J, Gerlinger C, Hamza A, Juhasz-Böss I, Solomayer EF. Safety and perioperative morbidity of laparoscopic sacropexy: a systematic analysis and a comparison with laparoscopic hysterectomy. Arch Gynecol Obstet 2016; 295:641-649. [PMID: 27896472 DOI: 10.1007/s00404-016-4240-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2016] [Accepted: 11/11/2016] [Indexed: 11/30/2022]
Abstract
PURPOSE The high prevalence of Pelvic Organ Prolapse (POP) along with the demographic trend of the ageing population raises the value of sacropexy in the treatment of POP. Thus, efforts to decrease risks associated with this procedure have the potential for public health impact. We examined the perioperative morbidity of laparoscopic sacropexy regarding the surgical access and compared it with the morbidity of one of the most common gynecological procedure, the laparoscopic hysterectomy. Our aim was to prove the safety of laparoscopic sacropexy. METHODS A retrospective evaluation of 80 consecutive laparoscopic sacropexies performed from Sept. 2012 until Oct. 2014 and 126 laparoscopic hysterectomies for a benign indication were undertaken. We assessed the anatomical outcome and the intra- and postoperative complications using the classification system according to Clavien-Dindo (CD). RESULTS Apical success rate after sacropexy was 100% and global success rate was 95% (POP-Q stage ≤1). The decline in hemoglobin was low in both groups and showed no statistically significant differences. Both operative time (P < 0.001) and the duration of hospitalization (P < 0.001) were longer in case of a sacropexy. Although overall intraoperative complications seemed more frequent during a sacropexy, differences were not statistically significant. Both early and late postoperative complications showed a higher rate of mild complications (CD-I/II) and a lower rate of severe complications (CD-IIIa/IIIb) after a sacropexy. The differences were not statistically significant. CONCLUSION The laparoscopic sacropexy represents a safe procedure with good anatomical outcome. Despite higher technical severity, it doesn't seem to bare higher risks for perioperative morbidity than the laparoscopic hysterectomy does.
Collapse
Affiliation(s)
- R Joukhadar
- Frauenklinik und Poliklinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 4, Haus C15, 97080, Würzburg, Germany. .,Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany.
| | - S Baum
- Campus Lübeck Abteilung für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.,Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - J Radosa
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - C Gerlinger
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - A Hamza
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - I Juhasz-Böss
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - E-F Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| |
Collapse
|
35
|
Joukhadar R, Herr D, Hamza A, Meyberg-Solomayer G, Takacs Z, Baum S. Diagnose und Management des retroflexio uteri gravidi mit akutem Harnverhalt in der Schwangerschaft in einer Fallserie von 6 Fällen. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
36
|
Joukhadar R, Wulff C, Solomayer E, Hamza A, Baum S. Darstellung und laparoskopische Behandlung einer vesicovaginalen Fistel in zwei Fallbeispielen. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
37
|
Joukhadar R, Baum S, Solomayer EF, Radosa J, Paulus V, Bettin S, Rhein D, Pauli F, Wöckel A. Sicherheit und Outcome von netzgestützten urogynäkologischen Eingriffen im hohen Alter. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
38
|
Aoun J, Baum S, Buekers T, Schiff L, Eisenstein D, Tsafrir Z, Stovall D. A Comparative Study of Clinical Characteristics and Preoperative Findings of Different Sarcoma Types. J Minim Invasive Gynecol 2016; 22:S48. [PMID: 27679253 DOI: 10.1016/j.jmig.2015.08.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- J Aoun
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - S Baum
- Wayne State University, Wayne State University, Detroit, Michigan
| | - T Buekers
- Gynecology Oncology, Henry Ford Hospital, Detroit, Michigan
| | - L Schiff
- Minimally Invasive Gynecologic Surgery, University of North Carolina, Chapel Hill, North Carolina
| | - D Eisenstein
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - Z Tsafrir
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - D Stovall
- Obstetrics and Gynecology, Riverside Health System, Newport News, Virginia
| |
Collapse
|
39
|
Aoun J, Baum S, Buekers T, Schiff L, Theoharis E, Tsafrir Z. A Comparative Study of Preoperative Findings and Outcomes in Pre-Menopausal and Post-Menopausal Women With Leiomyosarcoma. J Minim Invasive Gynecol 2016; 22:S228. [PMID: 27679116 DOI: 10.1016/j.jmig.2015.08.802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- J Aoun
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - S Baum
- Wayne State University, Wayne State University, Detroit, Michigan
| | - T Buekers
- Gynecology Oncology, Henry Ford Hospital, Detroit, Michigan
| | - L Schiff
- Minimally Invasive Gynecologic surgery, University of North Carolina, Chapel Hill, North Carolina
| | - E Theoharis
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - Z Tsafrir
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| |
Collapse
|
40
|
Aoun J, Baum S, Buekers T, Schiff L, Eisenstein D, Tsafrir Z, Stovall D. A Comparative Study of the Methods of Diagnosis and Outcomes of Different Uterine Sarcoma Types. J Minim Invasive Gynecol 2016; 22:S229-S230. [PMID: 27679119 DOI: 10.1016/j.jmig.2015.08.808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- J Aoun
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - S Baum
- Wayne State University, Wayne State University, Detroit, Michigan
| | - T Buekers
- Gynecology Oncology, Henry Ford Hospital, Detroit, Michigan
| | - L Schiff
- Minimally Invasive Gynecologic Surgery, University of North Carolina, Chapel Hill, North Carolina
| | - D Eisenstein
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - Z Tsafrir
- Minimally Invasive Gynecologic Surgery, Henry Ford Hospital, West Bloomfield, Michigan
| | - D Stovall
- Obstetrics and Gynecology, Riverside Health System, Newport News, Michigan
| |
Collapse
|
41
|
Radosa JC, Radosa CG, Kastl C, Mavrova R, Gabriel L, Gräber S, Wagenpfeil G, Baum S, Hamza A, Joukhadar R, Juhasz-Böss I, Heimes AS, Meyberg-Solomayer G, Solomayer EF, Radosa MP. Influence of the Preoperative Decision-Making Process on the Postoperative Outcome after Hysterectomy for Benign Uterine Pathologies. Geburtshilfe Frauenheilkd 2016; 76:383-389. [PMID: 27134293 DOI: 10.1055/s-0041-110396] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
Introduction: The aim of this study was to assess whether the preoperative decision-making process might influence treatment success in premenopausal women undergoing hysterectomy for benign uterine pathologies Materials and Methods: All premenopausal women treated with hysterectomy for benign uterine pathologies between April 2011 and June 2013 at a tertiary university center were enrolled in this prospective observational cohort study. Five parameters of the preoperative decision-making process were assessed upon their correlation with postoperative quality of life, sexual function and patients' satisfaction. These outcome measures were assessed for the pre- and postoperative (six months after surgery) status using two validated questionnaires (EQ-5D and "female sexual function index" (FSFI). Patients' satisfaction with the postoperative outcome was assessed with a self-developed questionnaire. Results: 255 of 402 (63 %) patients completed the study. A correlation between the co-variables "interval between first counseling and decision to surgery", "subjectively perceived quality of the preoperative counseling" and "certainty in the decision for the intervention" and postoperative outcomes were found. The co-variables "person mainly responsible for election of hysterectomy mode" and "discussion of decision for surgery with others" showed no influence on postoperative patients-reported outcomes. Conclusion: We found a correlation between certain parameters of the preoperative decision-making process and postoperative patient-reported sexual function, quality of life and patients' satisfaction in premenopausal women undergoing hysterectomy for benign uterine pathologies. An optimization of these factors could contribute to an improvement in treatment outcomes.
Collapse
Affiliation(s)
- J C Radosa
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - C G Radosa
- Institut und Poliklinik für radiologische Diagnostik, Universitätsklinikum Carl Gustav Carus Dresden, Dresden
| | - C Kastl
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - R Mavrova
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - L Gabriel
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - S Gräber
- Fachrichtung Medizinische Biometrie, Epidemiologie und Medizinische Informatik, Universität des Saarlandes, Campus Homburg/Saar, Homburg/Saar
| | - G Wagenpfeil
- Fachrichtung Medizinische Biometrie, Epidemiologie und Medizinische Informatik, Universität des Saarlandes, Campus Homburg/Saar, Homburg/Saar
| | - S Baum
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - A Hamza
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - R Joukhadar
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - I Juhasz-Böss
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - A-S Heimes
- Klinik für Geburtshilfe und Frauenkrankheiten, Johannes Gutenberg Universität, Mainz
| | - G Meyberg-Solomayer
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - E-F Solomayer
- Universitätsfrauenklinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum Homburg, Homburg
| | - M P Radosa
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena
| |
Collapse
|
42
|
Hamza A, Meyberg-Solomayer G, Juhasz-Böss I, Joukhadar R, Takacs Z, Solomayer EF, Baum S, Radosa J, Mavrova L, Herr D. Diagnostic Methods of Ectopic Pregnancy and Early Pregnancy Loss: a Review of the Literature. Geburtshilfe Frauenheilkd 2016; 76:377-382. [PMID: 27134292 DOI: 10.1055/s-0041-110204] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
This review article presents recent evidence on early pregnancy loss and ectopic pregnancy. In the light of recent evidence, the β-hCG discriminatory zone may be extended in clinically stable cases without evidence of bleeding. A possible cut-off is 4300 mIU/ml, which corresponds to when a sonographer should detect an intrauterine pregnancy. Embryonic demise can be confirmed when a transvaginal ultrasound finding shows no heartbeat in an embryo of more than 7 mm CRL, no embryo in a gestational sac having a mean sac diameter of more than 25 mm, or no appearance of an embryo within 7-10 days after the primary examination. These are considered definitive signs of embryonic demise. Suggestive signs of embryonic demise require closer monitoring of the pregnancy.
Collapse
Affiliation(s)
- A Hamza
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - G Meyberg-Solomayer
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - I Juhasz-Böss
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - R Joukhadar
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - Z Takacs
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - E-F Solomayer
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - S Baum
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - J Radosa
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - L Mavrova
- Department of Obstetrics and Gynaecology, Homburg University Medical Centre, Homburg
| | - D Herr
- Department of Obstetrics and Gynaecology, Würzburg University Medical Centre, Würzburg
| |
Collapse
|
43
|
Allan E, Barney C, Baum S, Kessling T, Diavolitsis V, Blakaj D, Grecula J, Rocco J, Van Putten M, Bhatt A. Low-Level Laser Therapy and Laser Debridement for Management of Oral Mucositis in Patients With Head and Neck Cancer Receiving Chemotherapy and Radiation. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2015.12.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
44
|
Friedrich M, Swords D, Altgassen C, Baum S, Kramer S. Alloplastic breast reconstruction after mastectomy. EUR J GYNAECOL ONCOL 2016; 37:622-626. [PMID: 29786998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The aim of reconstruction with expanders is to restore breast shape and volume as close as possible to the contralateral breast and to reconstruct the inframammary fold with adequate ptosis.
Collapse
|
45
|
Hamza A, Solomayer EF, Takacs Z, Juhasz-Boess I, Joukhadar R, Baum S, Radosa J, Mavrova R, Von Heesen A, Wagenpfeil S, Meyberg-Solomayer G. Einführung eines praktischen standardisierten Ultraschallkurses in der Medizinlehre. Z Geburtshilfe Neonatol 2015. [DOI: 10.1055/s-0035-1566641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
46
|
Solomon M, Greenberger S, Baum S, Pavlotsky F, Barzilai A, Schwartz E. Unusual forms of cutaneous leishmaniasis due to Leishmania major. J Eur Acad Dermatol Venereol 2015; 30:1171-5. [PMID: 26347371 DOI: 10.1111/jdv.13220] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2015] [Accepted: 05/21/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND Cutaneous leishmaniasis (CL) due to Leishmania major (L. major) is common in the Middle East; however, this skin infection may be under-diagnosed when it presents atypically. OBJECTIVE To highlight the occurrence of uncommon presentations of CL that may elude diagnosis. MATERIALS AND METHODS A retrospective study was performed among patients who presented at The Sheba Medical Center between 2005 and 2014 with atypical clinical presentations of CL due to L. major. RESULTS Twelve patients with unusual clinical presentations of L. major CL were identified. All infections were acquired in L. major - endemic areas of Israel. The average age was 37 years. The average number of lesions was 2. Nine patients presented with a form that mimicked other forms of CL, such as lupoid, giant ulcer, sporotrichoid and recidivans, and three had a variant resembling other infectious skin diseases, such as erysipeloid and verruciform. All patients required systemic therapy. CONCLUSION Cutaneous leishmaniasis due to L. major can masquerade as many other infectious and inflammatory diseases. In addition, it can mimic clinical forms of New World CL. We suggest that in endemic countries or in travellers returning from countries where L. major is endemic, polymerase chain reaction (PCR) for Leishmania-specific DNA should be performed routinely in cases of unusual presentations of dermatitis with a single or a few lesions, even if a diagnosis of CL was not considered by the referring clinician.
Collapse
Affiliation(s)
- M Solomon
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - S Greenberger
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - S Baum
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - F Pavlotsky
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - A Barzilai
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - E Schwartz
- Center for Geographic Medicine and Tropical Diseases, Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|
47
|
Kasoha M, Baum S, Solomayer EF. The role of Dickkopf-1 protein, an antagonist of the Wnt/β-catenin signaling pathway, in endometriosis. Geburtshilfe Frauenheilkd 2015. [DOI: 10.1055/s-0035-1558357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
48
|
Baum S, Meyberg-Solomayer G, Baum A, Radosa J, Hamza A, Gronwald B, Friedrich M, Solomayer EF, Joukhadar R. Deciding Factors for the Referral of a Female Patient to a Specific Hospital from the Viewpoint of Practice-Based Specialists. Geburtshilfe Frauenheilkd 2015; 75:456-461. [PMID: 26097249 DOI: 10.1055/s-0035-1546035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2014] [Revised: 03/17/2015] [Accepted: 04/06/2015] [Indexed: 10/23/2022] Open
Abstract
Background: One of the key points of patient care is the cooperation between practice-based specialists and clinical facilities. The present study was undertaken in order to illustrate the deciding factors, from the viewpoint of practice-based specialists, for the referral of a female patient to a specific hospital. Methods: Altogether a total of 322 practice-based specialists from various disciplines were contacted in writing and sent a questionnaire. In this survey the recipients were questioned about the criteria, in order of importance, applied for the referral of a (female) patient to a specific clinical facility. Results: In the foreground for the referral of a patient to a specific hospital are the aspects of medical quality and competence. On a closer look we find the surgical spectrum, especially the availability of endoscopic and special operations as a main factor. Further factors are a low rate of complications and the availability of modern diagnostic methods. Also evaluated as an important aspect was the easy reachability of a competent consultant. Factors of lower relevance for referral behaviour were personal familiarity with the colleagues employed in the hospital, specific further training events and the course of previous cooperation. Conclusions: A modern diagnostic and therapeutic spectrum coupled with an easy reachability of competent contact partners are the main factors for cooperation from the viewpoint of the practice-based specialist. Of lowest relevance, among others, was the aspect of previous cooperation. Thus, it can be seen that by means of changes in cooperation an improvement in patient care can be achieved at any time.
Collapse
Affiliation(s)
- S Baum
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - G Meyberg-Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - A Baum
- Praxis Prof. Dr. Dhom & Partner, Ludwigshafen
| | - J Radosa
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - A Hamza
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - B Gronwald
- Zentrum für Palliativmedizin und Kinderschmerztherapie, Universitätsklinikum des Saarlandes, Homburg
| | | | - E F Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - R Joukhadar
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| |
Collapse
|
49
|
Baum S, Greenberger S, Pavlotsky F, Solomon M, Enk CD, Schwartz E, Barzilai A. Late-onset onchocercal skin disease among Ethiopian immigrants. Br J Dermatol 2014; 171:1078-83. [PMID: 24673403 DOI: 10.1111/bjd.13005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/24/2014] [Indexed: 11/27/2022]
Abstract
BACKGROUND Onchocerciasis is an infectious disease caused by the filaria Onchocerca volvulus. Very little is known regarding onchocerciasis imported from endemic to nonendemic areas. OBJECTIVES To evaluate pruritic dermatitis simulating atopic dermatitis in Ethiopian immigrants in Israel. PATIENTS AND METHODS A retrospective study of 27 Ethiopian immigrants to Israel was conducted. Demographics and clinical and laboratory data were collected. RESULTS Of the group of 27 patients, 10 (37%) were men and 17 (63%) were women. The average age at referral was 29 years. All of the patients emigrated from Kuwara, Ethiopia. Diagnosis was done by either positive skin snip test or immunoglobulin (Ig) G4 serology of onchocerciasis in 14 patients. The most common presentation was a combination of lichenified onchodermatitis with atrophy and depigmentation (36%). Eosinophilia and elevated IgE levels were common. Seventeen patients were treated with a single administration of oral ivermectin 200 μg mg(-1). Thirteen patients responded to the treatment. CONCLUSIONS Immigrants from endemic regions to developed countries presenting with pruritic diseases, especially those with a clinical picture suggestive of atopic dermatitis, should be evaluated for possible onchocerciasis infection. Ivermectin, a relatively safe and low-cost treatment, should be considered even in the absence of a proven disease. Physicians should have a high index of suspicion in patients with the corresponding residential history.
Collapse
Affiliation(s)
- S Baum
- Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | | | | | | | | | | | | |
Collapse
|
50
|
Juhasz-Böss I, Laschke MW, Müller F, Rosenbaum P, Baum S, Solomayer EF, Ulrich U. Endometriosis: Survey of Current Diagnostic and Therapeutic Options and Latest Research Work. Geburtshilfe Frauenheilkd 2014; 74:733-742. [PMID: 25221341 DOI: 10.1055/s-0034-1382884] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Revised: 06/29/2014] [Accepted: 06/30/2014] [Indexed: 01/21/2023] Open
Abstract
Endometriosis is one of the most frequent benign diseases in women of child-bearing age. The main symptoms are chronic upper abdominal pain and infertility. However, the aetiology and pathogenesis of endometriosis are as yet insufficiently clarified. Thus, therapy is mainly symptomatic with laparoscopic surgery being the gold standard. The aim of drug therapy is to achieve a hypo-oestrogenic condition. In cases of severe endometriosis and a desire to have children there is often an indication for assisted reproduction. The present article illustrates almost all current aspects on the diagnosis of and therapy of endometriosis. From the clinical viewpoint, emphasis is placed on the rare cases of deeply infiltrating endometriosis that are, however, accompanied with a high morbidity. Current therapeutic options in cases of infertility are also presented in more detail. Furthermore, special attention is paid to the latest research results from both clinical and basic research fields in order to demonstrate our current knowledge on the pathogenesis and, where possible, potentially related therapeutic options.
Collapse
Affiliation(s)
- I Juhasz-Böss
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - M W Laschke
- Institut für Klinisch-Experimentelle Chirurgie, Universität des Saarlandes, Homburg
| | - F Müller
- Klinik für Gynäkologie und Geburtshilfe, Martin-Luther-Krankenhaus, Berlin
| | - P Rosenbaum
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - S Baum
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - E F Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar
| | - U Ulrich
- Klinik für Gynäkologie und Geburtshilfe, Martin-Luther-Krankenhaus, Berlin
| |
Collapse
|